Corporate News
Charles River Laboratories (CRL) experienced a 1.68 % increase during a 24‑hour period that ended at 11:25 AM Central Europe on Monday, 26 th. The stock is currently trading at approximately USD 345.37 on major exchanges. The total share supply is 47.7 million.
Market Metrics
| Metric | Value |
|---|---|
| Market Capitalisation | USD 16.5 billion |
| 24‑hour Trading Volume | USD 284 million |
| 30‑day Price Change | +17.3 % since the end of the previous month |
| 200‑day Simple Moving Average | USD 218.11 |
| 52‑week High | USD 351.21 (22 Oct 2026) |
| 52‑week Low | USD 146.20 (19 May 2026) |
Performance of Related Stocks (24‑hour Period)
| Ticker | % Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| NTNX (Nutanix) | +1.48 % | USD 70.58 | USD 19.1 billion | 13.69 |
| RGLD (Royal Gold) | -3.11 % | USD 227.42 | USD 19.3 billion | 24.63 |
| NRG (Nrg Energy) | -2.19 % | USD 92.31 | USD 19.4 billion | 23.85 |
| SNX (Td Synnex) | +0.11 % | USD 247.34 | USD 19.7 billion | 15.17 |
| SOFI (SoFi) | -1.05 % | USD 14.62 | USD 18.9 billion | 30.74 |
Td Synnex (SNX) Corporate Action
Td Synnex Corp has filed for the quotation of a new class of securities on the Australian Securities Exchange. The new shares, linked to the company’s Equity Incentive Plan, will be issued in exchange for employee services and will carry a 12‑month transfer restriction from the issue date. These incentive‑award shares will rank equally with existing shares upon listing. The move aims to expand the company’s capital structure and reward key personnel.
SoFi (SOFI) Upcoming Earnings Announcement
SoFi Technologies Inc. is scheduled to release its latest quarterly results on 27 Oct, covering the quarter ended 30 Sep. Analysts forecast a modest increase in earnings per share (EPS) compared to the same period last year, with a slight decline in revenue expectations for the quarter. For the current fiscal year, projections indicate a higher EPS relative to last year, while revenue outlooks suggest a moderate rise. The upcoming announcement will confirm whether these projections are met and provide further guidance for the remainder of the fiscal year.
Company Overview – Charles River Laboratories
Charles River Laboratories International, Inc. is a healthcare sector company headquartered in Wilmington, United States. The company supplies research tools and support services for drug discovery and development, specializing in animal research models for new drugs, devices, and therapies. Its client base includes pharmaceutical and biotechnology firms, hospitals, and academic institutions worldwide. The company is listed on the New York Stock Exchange and conducted its initial public offering on 23 June 2000. Further information is available on its website at www.criver.com .
